Yajing Chen compensation by year
Zai Lab Summary Compensation Table · the one fiscal year held| Component | FY2025 |
|---|---|
| Salary | $520,000 |
| Bonus | $0 |
| Stock awards | $1,207,100 |
| Option awards | $1,234,968 |
| Non-equity incentive | $205,920 |
| Pension and deferred compensation | $0 |
| All other | $17,500 |
| Total | $3,185,488 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Zai Lab Ltd DEF 14A filed April 28, 2026, accession 0001704292-26-000030, and prior-year filings. Open the filing on EDGAR.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 26,677 | $980,071 | — |
| RSU | 41,274 | $728,073 | — |
| RSU | 17,035 | $300,497 | — |
| RSU | 11,924 | $210,339 | — |
| RSU | 6,250 | $110,250 | — |
| RSU | 5,000 | $88,200 | — |
| RSU | 3,000 | $52,920 | — |
| RSU | 2,500 | $44,100 | — |
| RSU | 920 | $16,229 | — |
| Option | 8,000 | — | $45.47 |
| Option | 63,498 | — | $16.72 |
| Option | 52,418 | — | $35.55 |
Per the Outstanding Equity Awards at Fiscal Year-End table in Zai Lab Ltd's FY2025 proxy; value at the fiscal year-end close, as the company printed it. The 12 largest of 15 award rows shown.
Insider transactions since the last proxy
8 Form 4 lines since the FY2025 proxy (filed April 28, 2026)current to 2026-09-24 · updated nightly
| Date | Transaction | Plan | Shares | Price | Held after |
|---|---|---|---|---|---|
| 2026-08-19 | Sale | 10b5-1 | 260 | $27.00 | 35,635 |
| 2026-08-14 | Tax withholding | — | 427 | $25.90 | 35,895 |
| 2026-08-14 | Exercise or conversion derivative | — | 1,250 | $0.00 | 1,250 |
| 2026-08-14 | Exercise or conversion | — | 1,250 | — | 36,322 |
| 2026-08-11 | Sale | 10b5-1 | 619 | $25.00 | 35,072 |
| 2026-06-26 | Sale | — | 2,264 | $17.46 | 35,691 |
| 2026-06-25 | Exercise or conversion | — | 6,250 | — | 37,955 |
| 2026-06-25 | Exercise or conversion derivative | — | 6,250 | $0.00 | 0 |
The 8 most recent of 8 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →
Zai Lab’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| Samantha Du | Founder, Chief Executive Officer, and Chairperson of the Board of Directors | $10,677,221 |
| Josh Smiley | President and Chief Operating Officer | $4,700,527 |
| Rafael Amado | President, Head of Global Research and Development | $4,010,205 |
| F. Ty Edmondson | Chief Legal Officer and Corporate Secretary | $3,284,432 |
| Yajing Chen · this page | Chief Financial Officer | $3,185,488 |
The full Zai Lab compensation record
free company briefThis page is one person within Zai Lab's record. The company brief lists every named executive, each linking to their own page.
Compensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order Zai Lab's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Zai Lab's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Velarion Pro: every company page, peer tools and exports, one seat